Cargando…

RNA-Based Vaccines in Cancer Immunotherapy

RNA vaccines traditionally consist of messenger RNA synthesized by in vitro transcription using a bacteriophage RNA polymerase and template DNA that encodes the antigen(s) of interest. Once administered and internalized by host cells, the mRNA transcripts are translated directly in the cytoplasm and...

Descripción completa

Detalles Bibliográficos
Autores principales:	McNamara, Megan A., Nair, Smita K., Holl, Eda K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668311/ https://www.ncbi.nlm.nih.gov/pubmed/26665011 http://dx.doi.org/10.1155/2015/794528

Ejemplares similares

Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models
por: Holl, Eda K., et al.
Publicado: (2016)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018)

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
por: Holl, Eda K., et al.
Publicado: (2019)

DC-Based Vaccines for Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2020)

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
por: Brown, Michael C., et al.
Publicado: (2021)

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
por: Huff, Amanda L., et al.
Publicado: (2022)

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
por: Sayour, Elias J, et al.
Publicado: (2015)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
por: Chandran, Smita S., et al.
Publicado: (2019)

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
por: Park, Yeong-Min, et al.
Publicado: (2013)

Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection
por: Den, Robert B., et al.
Publicado: (2019)

Membrane Omega-3 Fatty Acid Deficiency as a Preventable Risk Factor for Comorbid Coronary Heart Disease in Major Depressive Disorder
por: McNamara, Robert K.
Publicado: (2009)

Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
por: Holl, Eda K., et al.
Publicado: (2019)

mRNA vaccines for cancer immunotherapy
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2022)

OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal
por: Linch, Stefanie N., et al.
Publicado: (2015)

Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
por: Noguera-Ortega, Estela, et al.
Publicado: (2020)

Purification Methods and the Presence of RNA in Virus Particles and Extracellular Vesicles
por: Zhou, Yijun, et al.
Publicado: (2020)

Oncolytic poliovirus directs tumor antigen presentation and T cell activation in vitro
por: Brown, Michael C, et al.
Publicado: (2015)

DNA vaccine for cancer immunotherapy
por: Yang, Benjamin, et al.
Publicado: (2015)

Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation
por: Messamore, Erik, et al.
Publicado: (2016)

The use of RNA-based treatments in the field of cancer immunotherapy
por: Chehelgerdi, Mohammad, et al.
Publicado: (2023)

Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
por: Sharma, Prashant, et al.
Publicado: (2019)

Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report
por: McNamara, Megan A, et al.
Publicado: (2015)

Therapeutic cancer vaccines and combination immunotherapies involving vaccination
por: Nguyen, Trang, et al.
Publicado: (2014)

Distinct features of dendritic cell-based immunotherapy as cancer vaccines
por: Lee, Chaelin, et al.
Publicado: (2018)

Vaccination and immunotherapies in neuroimmunological diseases
por: Winkelmann, Alexander, et al.
Publicado: (2022)

RNA-electroporated T cells for cancer immunotherapy
por: Pohl-Guimarães, Fernanda, et al.
Publicado: (2020)

RNA Vaccination Therapy: Advances in an Emerging Field
por: Kreiter, Sebastian, et al.
Publicado: (2016)

Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies
por: Keesing, Sharon, et al.
Publicado: (2014)

Next generation self-replicating RNA vectors for vaccines and immunotherapies
por: Aliahmad, Parinaz, et al.
Publicado: (2022)

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
por: Phua, Kyle K. L., et al.
Publicado: (2014)

Vaccines and Immunotherapy
por: Actor, Jeffrey K.
Publicado: (2019)

Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
por: Hargrave, Anna, et al.
Publicado: (2023)

RNA Nanotechnology-Mediated Cancer Immunotherapy
por: Lin, Yao-Xin, et al.
Publicado: (2020)

mRNA therapeutics in cancer immunotherapy
por: Beck, Jan D., et al.
Publicado: (2021)

mRNA delivery in cancer immunotherapy
por: Zhong, Yichen, et al.
Publicado: (2023)

The Fifty Year Rehabilitation of the Egg
por: McNamara, Donald J.
Publicado: (2015)

Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
por: Duan, Li-Juan, et al.
Publicado: (2022)

Building a pharmacy workforce from the ground up to support the COVID‐19 vaccine rollout: lessons learned and recommendations
por: Patanwala, Asad E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2n6ilaqd6oj97gl4lo7d7bu8bq